We found significantly higher expression of ZIP6 (Figure 2A; p = 0.0429), ZIP9 (Figure 2B; p = 0.0070) and ZIP10 (Figure 2C; p = 0.0171) in treatment‐naïve AML patients. Here, SLC39A9 is linked to acute myeloid leukemia.